ArticleEuropean journal of nuclear medicine and molecular imaging2026
Sex-specific differences in patients with differentiated thyroid carcinoma and their possible impact on survival.
Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to analyze survival outcomes in patients with differentiated thyroid cancer (DTC) compared to the general population, with particular focus on sex distribution, UICC staging, and age-specific mortality patterns.
methodsA retrospective survival analysis was conducted on 3186 DTC patients with extended follow-up. Overall survival (OS) and relative survival (RS; observed survival in patients/expected survival in population) were compared to age- and sex-matched general population data, using Monte-Carlo simulation. Multivariate Cox regression analysis was performed to identify independent prognostic factors.
resultsFemale predominance was confirmed in younger age groups with balanced distribution in the 40- to < 55-year cohort. DTC patients demonstrated superior OS compared to the general population, with improving RS over time. Female patients showed better survival outcomes than males and exceeded general population survival, while male patients achieved comparable survival. UICC stage I showed significantly lower mortality than all other stages. Only stage IVb consistently demonstrated worse outcomes than the general population. All age groups showed equal to superior survival compared to the general population, with patients ≥ 55 years demonstrating significantly improved RS from 5 years onward. Multivariate analysis identified sex, age at diagnosis, and UICC stage as independent prognostic factors for death.
conclusionThis analysis confirms generally favorable prognosis for DTC patients, demonstrating superior survival compared to the general population, due to increased health consciousness but also reflects the highly effective therapeutic regimen. Only patients ≥ 55 years with distant metastases (UICC stage IVb) consistently showed worse survival than the general population, emphasizing the critical importance of preventing disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.